FDA Inspection 649036 — Oklahoma Blood Institute

Oklahoma Blood Institute — FEI 3008629186

The FDA completed an inspection of Oklahoma Blood Institute on February 9, 2010 in Fort Smith, AR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 9, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Fort Smith, AR (United States)

Citations

IDCFRDescription
6121 CFR 606.60(a)Provide proper equipment to meet requirements